Sinovac Biotech Ltd. (NASDAQ: SVA) extended the deadline for shareholders to submit payment instructions for its previously declared special cash dividend. The company moved the submission deadline from December 31, 2025 to June 30, 2026.

The Chinese biopharmaceutical company announced a special cash dividend of $55.00 per common share, payable to shareholders who held shares as of the close of business on May 23, 2025. Shareholders and nominee brokers must submit completed instruction materials by the new deadline to receive the dividend payment.

D.F. King & Co., Inc. serves as the information agent for the dividend process. Shareholders with questions about the payment process can contact the agent at [email protected] with the subject line "Sinovac Biotech Ltd, Special Dividend."

The company specializes in research, development, manufacturing and commercialization of vaccines for human infectious diseases. Its portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease, poliomyelitis and pneumococcal disease.